Jean-Simon Diallo
Senior Scientist, Cancer Research
Ottawa Hospital Research Institute
Associate Scientist, Faculty of Medicine
University of Ottawa
Contact
613-737-8899 x 75203
Ottawa Hospital Research Institute Centre for Cancer Therapeutics 501 Smyth Road Box 926 Ottawa, ON K1H 8L6
Research Groups
Diallo Lab
Bio
Dr. Jean-Simon Diallo obtained his Master’s degree in Biochemistry at McGill University in 2003 and his Ph.D in molecular biology at the Université de Montréal in 2008. During his postdoctoral fellowship, Dr. Diallo worked on using oncolytic viruses to treat cancer and discovered a host of small molecules that enhance viral infection. He is now a Senior Scientist at the Ottawa Hospital Research Institute and Associate Professor at the University of Ottawa in the department of Biochemistry Microbiology and immunology. Dr. Diallo is an expert in cellular innate immunity and has over a decade of experience in research commercialization and translational development of viral vectors.
News
Publications
Optimization of YF17D-Vectored Zika Vaccine Production by Employing Small-Molecule Viral Sensitizers to Enhance Yields
2025-07-01 Go to publicationCharacterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
2021-02-01 Go to publicationFirst-in-class small molecule potentiators of cancer virotherapy
2016-01-01Combination of Paclitaxel and MG1 oncolytic virus as a successful strategy for breast cancer treatment
2016-01-01Single-particle characterization of oncolytic vaccinia virus by flow virometry
2016-01-01Related Research at The Ottawa Hospital
- Cancer Research Program
- COVID-19
- Cancer
- Infectious disease
- Discovery research
- Drug development
- Gene therapy
- Immunization
- Immunotherapy
- Molecular and cellular biology
- Translational research
- Viral therapy
- Cancer immunotherapy
- Oncolytic viruses
- Cancer biotherapeutics
- Artificial intelligence and data science